Detection and quantitation of dG-AAI and dA-AAI adducts by 32P-postlabeling methods in urothelium and exfoliated cells in urine of rats treated with aristolochic acid I.
Analysis of aristolochic acid I (AAI)-DNA adducts in exfoliated cells in urine, urothelium and entire urinary bladder were studied after oral administration of five daily doses (10 mg/kg body wt) AAI for 3 months to rats. The two major adducts excreted in urine are presumably identical to the two main adducts formed in vitro and in vivo in different organs in the rat, which have previously been characterized in vitro as 7(-deoxyguanosin-N2-yl)-aristolactam I and 7(-deoxyadenosin-N6-yl)-aristolactam I. Urine samples were collected on dry-ice, subsequently pooled and purified according to the protocol of Kadlubar and co-workers. DNA was isolated, digested and AAI-DNA adducts of exfoliated cells in urine and urothelium of rats were detected and quantitated by enhancement methods of the 32P-postlabeling assay, namely nuclease P1 enrichment or butanol extraction. Autoradiograms indicated that adduct patterns in DNA derived from exfoliated cells in urine were very similar to those obtained from DNA isolated from tissues. Quantitative analysis of adducts revealed adduct levels declining for both adducts from DNA isolated from urothelium to DNA isolated from the entire urinary bladder to DNA isolated from exfoliated cells in urine. In general, count rates of two predominant AAI adducts were enhanced by butanol extraction approximately 3- to 8-fold when compared with the nuclease P1 digestion technique. The identity of the two major adducts was confirmed by co-chromatography with eluted spots from in vivo adducts by comparing mobilities on poly-(ethyleneimine)-cellulose plates. Microbiological investigations of the urine revealed no gross contamination with bacteria, so that the isolated DNA supposedly originated from exfoliated urothelial cells. This study indicates that 32P-postlabeling analysis can be used to monitor non-invasively the formation of carcinogen-DNA adducts in animals or humans exposed to carcinogens.
Fernando
R C
RC
Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg.
Schmeiser
H H
HH
Nicklas
W
W
Wiessler
M
M
D000241:Adenosine / Q000031:analogs & derivatives* / Q000032:analysis / Q000652:urine; D000818:Animals; D034341:Aristolochic Acids; D001345:Autoradiography; D002273:Carcinogens / Q000032:analysis / Q000494:pharmacology*; D004247:DNA / Q000032:analysis / Q000378:metabolism / Q000652:urine; D003839:Deoxyadenosines; D003849:Deoxyguanosine / Q000031:analogs & derivatives*; D004755:Enterobacteriaceae; D006151:Guanosine / Q000031:analogs & derivatives* / Q000032:analysis / Q000652:urine; D007553:Isotope Labeling / Q000379:methods; D008297:Male; D010616:Phenanthrenes / Q000032:analysis / Q000494:pharmacology* / Q000652:urine*; D010761:Phosphorus Radioisotopes; D051381:Rats; D017208:Rats, Wistar; D015719:Single-Strand Specific DNA and RNA Endonucleases / Q000378:metabolism; D001743:Urinary Bladder / Q000737:chemistry* / Q000166:cytology / Q000378:metabolism; D014551:Urinary Tract / Q000737:chemistry* / Q000166:cytology / Q000378:metabolism; D014556:Urine / Q000166:cytology / Q000382:microbiology
D034341:Aristolochic Acids; D002273:Carcinogens; D003839:Deoxyadenosines; D010616:Phenanthrenes; D010761:Phosphorus Radioisotopes; D006151:Guanosine; C077579:7-(deoxyguanosin-N(2)-yl)aristolactam I; C077580:7-(deoxyadenosin-N(6)-yl)aristolactam I; D004247:DNA; C000228:aristolochic acid I; D015719:Single-Strand Specific DNA and RNA Endonucleases; D003849:Deoxyguanosine; D000241:Adenosine